Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,235.00
Bid: 2,220.00
Ask: 2,250.00
Change: 5.00 (0.22%)
Spread: 30.00 (1.351%)
Open: 2,210.00
High: 2,235.00
Low: 2,210.00
Prev. Close: 2,230.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Mar 2018 07:00

RNS Number : 0538H
Craneware plc
08 March 2018
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Director's Exercise of Options

 

8 March 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, yesterday exercised two tranches of options over a total of 29,081 ordinary shares of 1p each ("Ordinary Shares"). The first tranche of 18,248 Ordinary Shares was exercised at a price of 335 pence per Ordinary Share. The second tranche of 10,833 Ordinary Shares was exercised at a price of 400 pence per Ordinary Share.

 

Following the exercise of these options, Mr Neilson holds 3,377,799 Ordinary Shares in the capital of the Company, representing 12.8% per cent. of the Company's issued share capital.

 

The exercise of options has been fulfilled via the issue of Ordinary Shares held in the Company's Employee Benefit Trust. There is therefore no change to the Company's issued share capital.

 

 For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

George Sellar

Hilary Buchanan

Nicole McDougall

Robyn Fisher

 

About Craneware

Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company's flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle - Chargemaster Management since 2006 and is part of Craneware's value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.

 

Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.

 

Learn more at www.craneware.com.

 

 

Appendix 1

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name:

Keith Neilson

 

2

Reason for the notification

 

a)

Position/Status:

 

Chief Executive Officer

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

 

a)

Name:

Craneware plc

 

b)

LEI:

213800O2CTJ1YFXNXG05

 

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the financial instrument:

Identification code:

Ordinary Shares

ISIN GB00B2425G68

 

b)

Nature of the transaction:

 

Exercise of Options

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£3.35

£4.00

18,248

10,833

d)

Aggregated price(s) and volume(s):

Price(s)

Volume(s)

£3.592

29,081

e)

Date of the Transaction:

 

7 March 2018

f)

Place of the Transaction:

Outside of a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAADPEESPEEF
Date   Source Headline
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSExtension of share buyback programme
15th Apr 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20242:14 pmRNSDividend Currency Election
21st Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSInterim Results
17th Jan 20247:00 amRNSTrading Update and Notice of Results
14th Dec 20234:29 pmRNSNotification of Major Holdings
12th Dec 20232:36 pmRNSNotification of Major Holdings
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSDividend Currency Election
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20236:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Statement
1st Nov 20232:38 pmRNSExercise of SAYE Options, Director Dealing & TVR
25th Oct 20237:00 amRNSDirector Share Purchase
17th Oct 20236:10 pmRNSPosting of Annual Report and Notice of AGM
17th Oct 20239:44 amRNSExtension of share buyback programme
17th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSBlock listing Interim Review
6th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20233:52 pmRNSVesting of Long Term Incentive Plan Awards
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.